Author： Rocchi Angela Miller Elizabeth Hopkins Robert B. Goeree Ron
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.30, Iss.3, 2012-03, pp. : 229-246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Multiple sclerosis: which strategy goes beyond expectations?
Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. :
Access to resources
Recommend
Can the Global Fund fulfil its expectations?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 457, 2004-01 ,pp. :
Canada's Common Drug Review: a positive effect on drug coverage?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 643, 2011-01 ,pp. :
What's NICE in new recommendations?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. :
Factors affecting negative Common Drug Review recommendations in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. :